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Background: Stem cell-fate is highly regulated by stem cell niche, which is composed of a distinct microenvironment,
including neighboring cells, signals and extracellular matrix. Bone marrow-derived mesenchymal stem cells (BM-MSCs)
are multipotent stem cells and are potentially applicable in wide variety of pathological conditions. However, the niche
microenvironment for BM-MSCs maintenance has not been clearly characterized. Accumulating evidence indicated
that heparan sulfate glycosaminoglycans (HS-GAGs) modulate the self-renewal and differentiation of BM-MSCs, while
overexpression of heparanase (HPSE1) resulted in the change of histological profile of bone marrow. Here, we inhibited
the enzymatic activity of cell-autonomous HPSE1 in BM-MSCs to clarify the physiological role of HPSE1 in BM-MSCs.
Results: Isolated mouse BM-MSCs express HPSE1 as indicated by the existence of its mRNA and protein, which includes
latent form and enzymatically active HPSE1. During in vitro osteo-differentiations, although the expression levels of
Hpse1 fluctuated, enzymatic inhibition did not affect osteogenic differentiation, which might due to increased
expression level of matrix metalloproteinase 9 (Mmp9). However, cell proliferation and colony formation efficiency
were decreased when HPSE1 was enzymatically inhibited. HPSE1 inhibition potentiated SDF-1/CXCR4 signaling axis
and in turn augmented the migratory/anchoring behavior of BM-MSCs. We further demonstrated that inhibition of
HPSE1 decreased the accumulation of acetylation marks on histone H4 lysine residues suggesting that HPSE1 also
modulates the chromatin remodeling.
Conclusions: Our findings indicated cell-autonomous HPSE1 modulates clonogenicity, proliferative potential and
migration of BM-MSCs and suggested the HS-GAGs may contribute to the niche microenvironment of BM-MSCs.
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Stem cells are featured by their asymmetric behaviors of
self-renewal and multipotentiality that are controlled by in-
trinsic genetic networks, which are modulated in response
to extrinsic signals from the stem cell niches [1,2]. Stem
cell niches are specialized local extracellular microenviron-
ments that regulate stem cells to maintain tissue homeo-
stasis and safeguards against excessive stem cell production* Correspondence: ihliu@ntu.edu.tw
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unless otherwise stated.that could lead to cancer [3]. Thus, the niche microenvir-
onment, which may compose of various types of cells,
paracrine factors, and the extracellular matrix (ECM), is
one of the most important issues in stem cell biology.
In mammals, the best understood niche is hemato-
poietic stem cells (HSCs) in the bone marrow in which
the mesenchymal stem cells (MSCs) have been suggested
to contribute to the HSCs niche [4-6]. MSCs are derived
from multiple developmental origins [7] and can be found
all over the adult body such as bone marrow, muscle,
visceral organs and adipose tissue [8-11]. Recent studies in
determining the niche of bone marrow-derived MSCs
(BM-MSCs) indicated that the physiological niche micro-
environment of various MSCs may reside around vascula-
ture and hence suggested that endothelial cells are part ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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planted bone marrow cells re-establish stem cell colony
around sinusoids along with the formation of a miniature
bone organ suggested that BM-MSCs share similar peri-
vascular niche microenvironment [13]. Unfortunately,
the detailed composition of this microenvironment
and how the niche of mouse BM-MSCs is maintained
remain elusive.
The ECM is composed of a complex mixture of
fibrous proteins, polysaccharides and proteoglycans
(PGs), which include a core protein and numerous cova-
lently attached glycosaminoglycans (GAGs) [14]. Several
lines of evidence indicated that sulfated GAGs in the
ECM, especially heparan sulfate proteoglycans (HSPGs),
modulate phenotypes of MSCs [15-18]. HSPGs, ubi-
quitously found in the ECM and on cell membrane of
animal tissues, involve in a wide range of biological
activities through their highly heterogenous HS-GAGs
chains [19-21]. Accumulating evidence showed that the
addition of HS-GAGs in the in vitro culture environ-
ment affects self-renewal and differentiation of BM-
MSCs [22,23]. However, an earlier study suggested the
absence of HS-GAGs in the bone marrow sinusoidal
basement membrane [24]. These findings imply that the
relatively low levels of HS-GAGs accumulation could be
an important feature for the niche of BM-MSCs and a
mechanism for the maintenance of this low HS-GAGs
microenvironment must exist.
Heparanase (HPSE1) is an endo-β-glucuronidase that
specifically degrades HS-GAGs and is the only known
endogenous HS-GAGs degrading enzyme in vertebrates.
Previous study showed that bone marrow osteoblasts ex-
press HPSE1 and ubiquitous overexpression of this gene
resulted in the increase of bone mass [25,26] suggesting
that osteogenesis from BM-MSCs is affected by environ-
mental HPSE1. Furthermore, the addition of bacterial
heparinase faciliated osteogenic differentiation of MSCs
via BMP signaling pathway [27]. In this study, we aimed
to test our hypothesis that the cell autonomous hepa-
ranase is involved in the maintenance of the niche
microenvironment of BM-MSCs and exploited heparanase
inhibitor, OGT2115, to study the roles of heparanase in
the fate determination of mouse BM-MSCs, including dif-
ferentiation, proliferation, and migration.
Methods
Animals
C57BL/6 mice of 6-8 weeks were purchased from the
Laboratory Animal Center of Medical College in National
Taiwan University (Taipei, Taiwan). Mice were kept under
standard conditions, and all experimental procedures on
animals were approved by the Institutional Animal Care
and Use Committee (IACUC) of National Taiwan University
(NTU-99-EL-87).Isolation of mouse BM-MSCs
Mouse BM-MSCs were harvested as previously described
[28]. Briefly, bone marrow cells were cultured with four
residual bone fragments together from 6- to 8-week-old
C57BL/6 mice on to 60-cm2 tissue culture dishes (TPP,
Trasadingen, Switzerland) at a density of 2 × 105 cells/cm2
in MEM alpha (Sigma-Aldrich, St. Louis, MO, USA)
supplemented with 20% fetal bovine serum (FBS; Hyclone,
Logan, UT, USA), 2 mM L-glutamine (Invitrogen,
Carlsbad, CA, USA), 100 U⁄mL penicillin and 100 μg/mL
streptomycin (Invitrogen). The cells were incubated at
37°C in a humidified atmosphere containing 95% air
and 5% CO2 for 72 h. The non-adherent cells were then
removed by changing the medium. When cells reached
70% confluence, cells were lifted by incubation with 0.25%
trypsin/0.1 mM ethylenediaminetetraacetic acid (trypsin/
EDTA; Invitrogen) for 3 min at 37°C.
The BM-MSCs were enriched by negative selection.
Cells were suspended in 90 μL of washing buffer per 107
cells and then incubated at 4°C for 15 min on magnetic
microbeads conjugated with antibodies either against
CD11b or CD45 (Miltenyi Biotec, Auburn, CA, USA)
according to the manufacturer’s instructions. The enriched
CD11b- and CD45- BM-MSCs were seeded at a concen-
tration of 5 × 104 cells/cm2 with heparanase inhibitor
OGT2115 or DMSO as vehicle control for the subse-
quent experiments.
Western blotting
To evaluate the protein levels, the cells (1 × 106) were
washed twice with ice-cold PBS and disrupted in 200 μL
of RIPA buffer (Thermo Scientific, Waltham, MA, USA).
Samples were centrifuged at 14,000 g for 15 min, and the
quantity of protein was determined by the BCA protein
assay reagent (Thermo Scientific). Samples (20 μg of pro-
tein) were separated by 8% and 12% SDS-polyacrylamide
gel electrophoresis (PAGE) for detecting HPSE1 and acet-
ylated histone H3/H4, respectively and subsequently
transferred onto an 0.22 μm PVDF membrane (Millipore,
Billerica, MA. USA) and probed with primary antibodies
which are rabbit anti-heparanase1 (Abcam, Cambridge,
UK), rabbit anti-acetyl-histone H3 (Millipore) and rabbit
anti-acetyl-histone H4 (Millipore). Histone H3 (rabbit
anti-histone H3; Millipore) and Histone H4 (rabbit anti-
histone H4; Millipore) were used as internal controls.
Quantitative analysis was done by using ImageJ software
(NIH) [29].
Immunocytochemistry
After the mouse BM-MSCs were seeded onto glass
coverslips for 24 hr, the cells were washed by PBS and
fixed by cold methanol for 10 min at -20°C. The cells
were then blocked by blocking buffer (5% BSA in PBS)
and incubated with rabbit anti-heparanase 1 (Abcam)

















Table 2 List of antibodies used in flow cytometric analysis
Antibody Clone Ref. no. Conjugated Isotype Supplier
CD31 390 12-0311 PE Rat IgG2a eBioscience
CD45 30-F11 12-0451 PE Rat IgG2b eBioscience
CD73 TY/11.8 12-0731 PE Rat IgG1 eBioscience
CD105 MJ7/18 12-1051 PE Rat IgG2a eBioscience
Sca-1 D7 12-5981 PE Rat IgG2a eBioscience
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and 8 kD subunits of HPSE1 at 4°C overnight. The anti-
rabbit IgG conjugated Alexa-594 (Invitrogen) was used as
the secondary antibody and the samples were mounted
with the mounting medium containing DAPI (Abcam).
Heparanase assay
After treated with the heparanase inhibitor (OGT2115),
the extracellular composition of HS-GAGs was evalu-
ated to test the inhibition effect of OGT2115. The pro-
teoglycans and glycosaminoglycans from cultured cells
were extracted by the extraction buffer (4 M guanidine
HCl, 0.05 M Na acetate (pH = 6.0), containing 2% (w/v)
Triton X-100 and protease inhibitors), and the quantities
of protein were determined by the BCA protein assay re-
agent (Thermo Scientific). To evaluate the composition
of HS-GAGs, 2 μL of sample (0.5 μg of protein) was
spotted onto the 0.22 μm PVDF membrane (Millipore).
After the membrane was dried, blocked by blocking
buffer (5% milk and 0.1% Triton X-100 in TBS) for 1 hr,
and incubated with primary antibody, mouse anti-
heparan sulfate IgM (10E4, Seikagaku, Tokyo, Japan), to
evaluate the complete heparan sulfate chain (10E4) con-
tent. Then chemiluminescence was performed by using
goat anti-mouse IgM and IgG conjugated HRP as a sec-
ondary antibody. The signal intensity was evaluated and
compared by ImageJ [29].
Quantitative real-time reverse transcription-polymerase
chain reaction (qPCR)
To evaluate the mRNA expression levels, total cellular
RNA was extracted using TRIzol reagent (Invitrogen)
and then treated with RNase free DNase Set (Promega,
Madison, MI, USA) according to manufacturer’s instruc-
tions. Reverse transcription reactions were performed
with 2 μg total RNA using the SuperScript First-Strand
Synthesis System (Invitrogen), according to the manufac-
turer’s instructions. Real-time PCR (Bio-Rad, Hercules,
CA, USA) was performed with 1 μL of the single-stranded
cDNA sample with SYBR Green PCR master mix (Bio-
Rad). The sequences of primers used were listed in Table 1.
The qPCR program started at 95°C for 3 min followed by
40 cycles of 95°C, 10s and 60°C, 30s. Each amplification
reaction was checked to confirm the absence of nonspe-
cific PCR product by melting curve analysis. The relative
gene expression level was calculated and presented with
the 2-ΔΔCt method. GAPDH was used as a reference gene
to normalize specific gene expression in each sample.
Flow cytometric analysis
To evaluate the identity of enriched BM-MSCs, cells were
immunostained with PE-conjugate monoclonal antibodies
(Table 2) for 30 min at 4°C in dark according to the manu-
facturer’s instructions. Ten thousand cells were acquiredon a Beckman Coulter FC500, and analyzed by FCS
Express software (Version 4.0; Denovo software, Los
Angeles, CA, USA). All experiments included negative
controls that stained without antibodies and with iso-
type controls (eBioscience, San Diego, CA).
In vitro osteogenic differentiation
To evaluate the osteogenic differentiation potentials,
BM-MSCs were cultured to near confluence and cul-
tured in osteogenic induction medium consisting of
MEM alpha (Sigma-Aldrich) supplemented with 10%
FBS (Hyclone), 0.1 μM dexamethasone (Sigma-Aldrich),
10 mM β-glycerolphosphate (Sigma-Aldrich) and 50 μM
ascorbic acid (Sigma-Aldrich) for 14 days [30]. The in-
duction medium was changed every 3 days, and the
bone matrix mineralization was evaluated by Alizarin
red S (ARS; Sigma-Aldrich) staining. The ARS was ex-
tracted by adding 10% cetylpyridinium chloride (Sigma)
in 8 mM Na2HPO4 (Merck, Darmstadt, Germany) and
1.5 mM KH2PO4 (Merck) and the absorbance was mea-
sured by SpectraMax 190 ELISA plate reader (Molecular
Devices, Sunnyvale, CA, USA) at 550 nm [31].
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To evaluate the cell proliferation, MTT (3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H- tetrazoliumbromide) assay was
performed as described previously [32]. Briefly, cells were
seeded at the density of 1.5 × 103 cells/well in 96 well plate
and cultured without or with various concentrations (0.1,
0.4, 1 μM) of OGT2115. Cells were analyzed every two
days by adding 10 μL of the MTT (5 mg/ml; Sigma-
Aldrich) to each well and the cells were continued to
culture for 4 hr. After the incubation, the supernatant was
discarded and 100 μL of dimethyl sulfoxide (DMSO,
Sigma-Aldrich) was added to each well to dissolve the
formazan. The number of cells was determined according
to the absorbance measured by SpectraMax 190 ELISA
plate reader (Molecular Devices) at 570 nm.
Colony formation assay
To evaluate the clonogenicity, the BM-MSCs were
plated at a density of 350 cells/9.01 cm2 culture dish
(TPP). After incubation for 9 days, the colonies formed
were fixed by methanol (Sigma-Aldrich) and stained with
Geimsa solution (Sigma-Aldrich) [33]. CFU numbers were
enumerated by a light microscope and a cluster of at least
20 cells was defined as a CFU.
Preparation of mouse recombinant HPSE1
To prepare the mouse recombinant HPSE1, full-length
coding sequence of the gene was purchased (OriGene,
Rockville, MD, USA) and subcloned into pIRES2-eGFP
(Clonetech, Mountain View, CA, USA) by PCR with a
FLAG-tag sequence added immediately before the stop
codon to generate pHPSE1-FLAG-IRES2-eGFP. The re-
sulted plasmid was transfected into 293T cells with
TransIT-LT1 transfection reagent (Mirus Bio, Madison,
WI, USA) according to the manufacturer’s instruction.
The culture medium was harvested 48 to 72 hr later,
reduced volume by concentrators with 10 kDa molecular
weight cut-off (GE Healthcare, Pittsburgh, PA, USA) and
the recombinant HPSE1 was purified with anti-FLAG
M2 magnetic beads (Sigma-Aldrich) according to the
manufacturer’s instruction. The buffer of the final eluent
was exchanged from 0.1 M Glycine-HCl (pH 3.0) to PBS
with concentrators. The resulted preparation was charac-
terized by SDS-PAGE and western blot and the concen-
tration was calibrated by BCA assay (Thermo Scientific).
Transwell cell migration assay
To evaluate the role of heparanase in modulating the
homing signals of BM-MSCs, 5 × 104 cells were seeded
on to transwells (6.5 mm, 8 μm pore; BD Biosciences,
Jose, CA, USA) in MEM alpha supplemented with 1%
FBS. MEM alpha with both 1% FBS and SDF-1 (200 ng/
mL; R&D Systems, Minneapolis, MN, USA) was added
to lower chamber. After 24 hr, non-migrating cells werewiped away slightly from the top surface of the mem-
brane. CXCR4 inhibitor groups were pre-treated with
AMD3100 (25 μg/mL; MERCK) for 1.5 hr. And the
upper chamber was treated with 2 μg heparanase or
0.4 μM OGT2115. Cells migrated to the undersurface of
the membrane were stained with hematoxylin (Vector
Lab, Burlingame, CA, USA) and counted.
DNA topoisomerase assay
To determine the influence of the heparanase activity on
the activity of DNA topoisomerase, the nuclear protein of
BM-MSCs with or without the treatment of OGT2115
was isolated and incubated with the topoisomerase I reac-
tion buffer (500 mM Tris-Cl, 1 M KCl, 10 mM dithiothre-
itol, 100 mM EDTA, 50 μg/ml acetylated bovine serum
albumin) and 200 ng of plasmid pUC19 at 37°C for
30 min. After incubation, the reaction contents were
loaded on the 0.8% agarose gel and run for 2 to 3 hr at 5
to 10 V/cm. The sample topoisomerase activity was then
relatively determined by the percentage of supercoiled
plasmid.
Statistical analysis
All experiments included at least 3 biological repeats
and all values were presented as mean ± standard devi-
ation. Statistical comparisons were analyzed with the
two-tailed Student’s t-test or one-way ANOVA with Tukey
multiple comparison. A P-value less than 0.05 was consid-
ered statistically significant.
Results
The expression of HPSE1 by mouse BM-MSCs and the
enzymatic inhibition by OGT2115
To test our hypothesis that cell autonomous heparanase
participated in the maintenance of stem cell niche, we first
demonstrated that mouse BM-MSCs express HPSE1. RT-
PCR (Figure 1A) and immunocytochemistry (Figure 1B)
showed that isolated BM-MSCs consistently express
HPSE1 at mRNA and protein levels. Heparanase is trans-
lated as a pro-enzyme and requires to be processed into a
smaller molecule to be enzymatically active. To clarify
whether heparanase expressed by isolated BM-MSCs is
enzymatically active, cell lysates were harvested for west-
ern blot. Western blot detected both intact heparanase
(68 kDa) and activated heparanase (50 kDa) (Figure 1C)
indicating that the BM-MSCs not only can express HPSE1
but also can activate it.
To assess the role of this enzyme in BM-MSCs, we
exploited the small molecule heparanase inhibitor
OGT2115 to block the enzymatic activity of heparanase.
Dot-blot of cell extracts with the addition of OGT2115
showed significantly stronger reactivity against complete
heparan sulfate chain (10E4) content antibody when com-
pared to the vehicle control (Figure 1D, 1E) indicating that
Figure 1 Mouse BM-MSCs express HPSE1 and can be enzymatically inhibited by OGT2115. (A) RT-PCR indicated the existence of mRNA of
Hpse1 in mouse BM-MSCs throughout serial passages. (B) Immunocytochemistry demonstrated the existence of HPSE1 protein (red) in the mouse
BM-MSCs, in which the nuclei were counter-stained by DAPI (blue). (C) Western blot indicated that enzymatically active form (50 kDa) of HPSE1
could be detected in mouse BM-MSCs. Gapdh was used as a loading control. (D, E) Dot blot assay of mouse BM-MSCs demonstrated mild reactivity
against 10E4 indicating a mild reservation of intact heparan sulfate glycosaminoglycans. The small molecule HPSE inhibitor, OGT2115, can repress the
enzymatic activity of HPSE indicated by the statistically stronger reactivity of 10E4.
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inhibited by OGT2115.
Inhibition of HPSE did not affect molecular phenotypes
and osteogenic differentiation
To assess whether the inhibition of HPSE alters extrinsic
signals and in turn affects stem cell property, we analyzedFigure 2 The inhibition of cell-autonomous HPSE1 did not affect the
analysis of MSCs markers, Sca-1, CD73, and CD105, hematopoietic cell marker
ment of OGT2115 (OGT) and the DMSO control. Inhibition of HPSE did not afa panel of surface markers of mouse MSCs. Mouse
BM-MSCs were positive for MSCs markers Sca-1,
CD73, and CD105, while negative for the hematopoietic
cell marker, CD45, and for the endothelial cell marker,
CD31 (Figure 2). These expression profiles remain identi-
cal not only through serial passages at passage 2 (P2)
(Figure 2), passage 4 (P4) (data not shown) and passage 7surface marker profiles of mouse BM-MSCs. Flow cytometric
, CD45, and the endothelial cell marker, CD31 on BM-MSCs by the treat-
fect these surface markers expressions on BM-MSCs.
Figure 3 The HPSE inhibitor OGT2115 did not affect osteogenic
differentiation of mouse BM-MSCs. (A) The expression levels of
Hpse1 increased during osteogenic differentiation. (B) Osteogenic
potential was characterized by ARS staining after 21 days induction at the
fourth passage of BM-MSCs with or without OGT2115. Quantifications of
ARS staining of OGT2115 and control groups showed no difference
(n = 3). (C) Quantitative real-time PCR analysis on the mRNA expression
levels of Mmp2, Mmp9 and Mmp14 with or without the treatment of
OGT2115 detected a significantly increased Mmp9 expression when HPSE1
is enzymatically inhibited. Error bars represent standard deviation.
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OGT2115 indicating that the inhibition of HPSE activity
does not alter the identity of BM-MSCs.
Previous studies indicated that environmental heparan
sulfate degrading activity enhanced the osteogenic differ-
entiation of BM-MSCs [25,27]. We therefore assessed
the potential role of HPSE1 in the osteogenic differenti-
ation of mouse BM-MSCs. In accordance with the previ-
ous results, RT-PCR showed that the Hpse1 expression
levels increased after induction for 3 days during osteo-
genic differentiation (Figure 3A). However, after 14 days
of induction, quantitative analysis of ARS staining did not
show significant difference between the control group and
the OGT2115 treated group (Figure 3B) indicating that
the reduction of heparanase activity does not affect the
osteogenic differentiations of mouse BM-MSCs.
Previous study suggested that the increased expressions
of various matrix metalloproteinases (MMPs) could com-
pensate the loss of heparanase in genetically knockout
mouse [34]. It is reasonable to speculate that at least one
of the MMPs is increased in response to and compensates
for the loss of the enzymatic activity of heparanase.
Accordingly, we observed a significantly higher Mmp9
expression level in HPSE-inhibited group than control
group although there were no difference in Mmp2 and
Mmp14 (Figure 3C). These data suggested that there are
redundant mechanisms modulating the environmental
heparan sulfate proteoglycans and the normal osteogenic
differentiation of MSCs under the HPSE-inhibited condi-
tion might due to the increase of MMP9.
Heparanase modulated cell proliferation and clonogenicity
of MSCs
In order to investigate whether HPSE plays a role in
self-renewal and proliferation of MSCs, we first evalu-
ated the proliferation potentials of the BM-MSCs with
or without the treatment of HPSE inhibitor by MTT
assay. The total cell number of HPSE-inhibited group
was lower than control group in a dose-dependent fash-
ion (Figure 4A) indicating that HPSE is important in the
expansion of BM-MSCs. Since the efficiency of population
expansion may correlated with the stemness of the stem
cells, it is reasonable to speculate that the clonogenicity is
affected by the treatment of HPSE inhibitor. We therefore
assessed the population of BM-MSCs that can expand into
a colony (consisted of more than 20 cells). In accordance
with our speculation, HPSE-inhibited group formed
significantly less CFUs than control group (Figure 4B)
suggesting that HPSE is important in autonomous main-
tenance of cell stemness.
Since the proliferation capacity of BM-MSCs decreases
along the serial passages [35,36], it is intriguing whether
the effect of HPSE inhibition on the proliferation of BM-
MSCs also changes. We therefore performed MTT assayon BM-MSCs 0, 2, 4 and 6 days after the treatment of
HPSE inhibitor for BM-MSCs at P2 (Figure 4C), P4
(Figure 4D) and P6 (Figure 4E). The results showed that
the inhibitory effect on cell proliferation could be con-
sistently observed. Interestingly, the cell numbers began
Figure 4 HPSE1 promoted self-renewal of mouse BM-MSCs. (A) Cell numbers were evaluated by MTT assay 0, 2, 4 and 6 days after the
treatment of various concentrations of OGT2115. The results revealed that OGT2115 inhibited cell proliferation of BM-MSCs at fourth passage in a
dose-dependent manner (n = 3). (B) The CFUs were significantly decreased by the treatment of OGT2115 (OGT) compared to the DMSO control,
while the combined treatment of both mouse recombinant HPSE1 and OGT2115 (O + H) reversed the statistical significance (n = 3). (C-E) The
inhibitory effect on BM-MSCs proliferation of OGT2115 was consistently reproduced at P2 (C), P4 (D) and P6 (E). *P < 0.05; **P < 0.01; ***P < 0.001.
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BM-MSCs (Figure 4C, D), while the statistical signifi-
cance were not detected until day 4 in P6 BM-MSCs
(Figure 4E).
Heparanase modulated the homing mechanism of BM-MSCs
via SDF-1/CXCR4 signaling axis
HSPGs modulate several signaling pathways via the
binding affinity of the covalently attached HS-GAGs to a
spectrum of signaling ligands and receptors [19-21,37].
It has been shown that the chemokine SDF-1/CXCR4
signaling axis plays a key role in the migration of mouse
MSCs [38,39], while accumulating evidence showed that
SDF-1 is modulated by HS-GAGs [18,39-42]. It is rea-
sonable to speculate that the autonomous expression of
HPSE1 also modulates the migration of mouse MSCs.
We analyzed the effect of migration through inhibition
of HPSE activity by using transwell assay, and the result
showed that the addition of SDF-1 significantly increased
the migratory cell count (Figure 5A). While OGT2115 fur-
ther increased the migratory cells significantly, CXCR4inhibitor significantly decreased the migratory cells re-
gardless of whether HPSE was inhibited (Figure 5A).
These results indicated that the inhibition of HPSE activity
enhanced chemotaxis and the blocking of CXCR4
significantly decreased this chemotaxis indicating that
HPSE modulates BM-MSCs homing via SDF-1/CXCR4
signaling axis.
To further demonstrate the specificity of the effect of
OGT2115 on migration, the transwell migration assay
with SDF-1 was repeated with or without the presence
of OGT2115 and/or mouse recombinant HPSE1. In
accordance with our hypothesis, the addition of mouse
recombinant HPSE1 demonstrated a trend of reduced
migratory BM-MSCs similarly to the CXCR4 inhibitor
and significantly reversed the potentiation of migration
by OGT2115 (Figure 5B) indicating that the effect of
OGT2115 is specifically through the inhibition of HPSE1
and that HPSE negatively modulates the migration of
BM-MSCs.
Like proliferation capacity, the migration ability of
BM-MSCs also decreased along the serial passages [43].
Figure 5 The inhibition of HPSE activity potentiated the chemotaxis of BM-MSCs. (A) The chemotaxis in response to SDF-1 was assayed in
P4 BM-MSCs with or without the presence of OGT2115 (OGT) and AMD3100 (AMD). The BM-MSCs were strongly mobilized by SDF-1/CXCR4
signaling axis as the migratory cells were increased with the presence of SDF-1, while the presence of OGT2115 further potentiated the migration.
The addition of AMD3100, the inhibitor of SDF-1/CXCR4 signaling pathway quench the migration with or without the presence of OGT2115
(n = 3). (B) To test the specificity of the OGT2115, the transwell migration was assayed with the presence of SDF-1. The addition of mouse HPSE1
(HPSE) demonstrated a similar trend of reduction in migratory BM-MSCs as AMD3100, while the potentiation of migration by OGT2115 can be
reversed by the addition of HPSE1 (n = 3). (C) The potentiation of BM-MSCS migration in response to SDF-1 by the presence of OGT2115 can
also be observed in P2 and P6 BM-MSCs. (D) qPCR analysis of migration related signals indicated that HPSE inhibitor transactivated the mRNA
expression level of Cxcr4 (n = 3). Error bars represent standard deviation. *P < 0.05; **P < 0.01; ***P < 0.001.
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assay with SDF-1 on P2 and P6 BM-MSCs. Consist-
ent with the experiments done with P4 BM-MSCs
(Figure 5A, B), inhibition on endogenous HPSE po-
tentiated the cell migration at both P2 and P6 BM-
MSCs (Figure 5C) indication that the effect of HPSE
on modulating BM-MSCs migration persist through
serial passages albeit the migration capacity decreased in
later passages.
Previous studies indicated that HS-GAGs interact with
SDF-1 directly and cell surface HSPGs mediate the SDF-
1/CXCR4 binding and signaling [44-46]. We would like
to know whether gene transactivation is also involved.
To answer this question, we analyzed migration related
genes including Sdf1 (Cxcl12), Cxcr7 and Cxcr4, and found
that the expression level of Cxcr4 increased significantly
under the treatment of HPSE inhibitor (Figure 5D) sug-
gesting that HPSE also modulates BM-MSCs via a gene
transactivation mechanism.Heparanase participated in chromatin remodeling
Previous studies indicated that nuclear HPSE and hepa-
ran sulfate glycosaminoglycans might participate in the
transcriptional regulation via the modulation of the
enzymatic activities of histone acetyltrasnferases (HAT)
such as p300 and DNA topoisomerase I [47-49]. Our re-
sults demonstrated the altered gene expression patterns
under the inhibition of HPSE (Figures 3C and 5D). We
hence hypothesized that HPSE could participate in the
maintenance of self-renewal of BM-MSCs, at least par-
tially, via this intranuclear mechanism involving in chro-
matin remodeling. To this end, universal histone H3- and
histone H4-acetylation in BM-MSCs were quantified by
western blot. Although the acetylation level of histone H3
was not altered compared to control group (Figure 6A),
inhibition of HPSE activity significantly decreased the
acetylation level of histone H4 (Figure 6B) suggesting
cell-autonomous HPSE may participate in the biolo-
gical regulation of BM-MSCs by modulating the acetylation
Figure 6 The inhibition of HPSE decreased the acetylation level on histone H4 lysine of mouse BM-MSCs. (A) Quantitative analysis of the
acetyl-histone H3 (H3Kac) normalized by total histone H3 (H3) of BM-MSCs showed no difference in the presence or absence of OGT2115. (B)
Quantitative analysis of the acetyl-histone H4 (H4Kac) normalized by total histone H4 (H4) of BM-MSCs. We observed significantly decreased
acetylation of histone H4 with the presence of OGT2115. Error bars represent standard deviation. (C) Quantitative analysis of DNA topoisomerase
activity with or without the treatment of OGT2115 showed similar levels of DNA topoisomerase activity. **P < 0.01 (n = 3).
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thermore, DNA topoisomerase assay showed similar en-
zymatic activities with or without the HPSE inhibition
(Figure 6C) suggesting that HPSE did not affect DNA
topoisomerase activity in mouse BM-MSCs.
Discussion
In this work, the strategy of loss-of-function was under-
taken to study the role of HPSE by using HPSE inhibitor,
OGT2115 [50]. Previous study showed that the bone
marrow stromal cells weakly express HPSE1 and this
expression level is increased along with the osteogenic
differentiation both in vivo and in vitro [25]. Furthermore,
the observation in transgenic mouse with ubiquitous
overexpression of HPSE suggested that HPSE promotes
the osteogenic differentiation [25]. Similarly, we demon-
strated that the isolated mouse BM-MSCs express HPSE1
throughout serial passages in the in vitro culture. The
markedly elevated expression pattern along with the
osteogenic differentiation of Hpse1 also strongly implied
that HPSE participates in the differentiation regulations of
mouse BM-MSCs. Surprisingly, our results indicated that
the loss of HPSE neither changed the profile of surface
markers, nor affected the outcome of adipo- (data not
shown) and osteo-differentiations. Interestingly, the HPSE
knockout mice do not have major abnormalities probably
due to the compensatory increased expression levels of
matrix metalloproteinases [34]. In accordance with this
finding, we also observed an increased expression level of
Mmp9 in HPSE-inhibited mouse BM-MSCs, which may
provide an explanation for the lack of effect on both
adipogenic and osteogenic differentiation potentials underthe deficiency of HPSE activity. Since HPSE is believed to
mediate many biological activities via the cleavage of the
HS-GAGs attached to the core proteins of HSPGs, our
finding also implies that part of the biological roles of
HPSE can be achieved by the cleavage of the core proteins
of HSPGs by MMPs.
Bone marrow is constituted by several types of cells
including at least two populations of stem cells, HSCs
and MSCs. Accumulating evidence suggested that BM-
MSCs play a key role as part of the microenvironment
niche for HSCs, and MSCs secreted several known HSCs
regulators including SDF-1 and Wnt5a [51-53]. In con-
trast to what we know about the niche microenviron-
ment of HSCs [54], little is known about how BM-MSCs
maintain the self-renewal while contribute to the tissue
renewal of endosteum. Due to their vicinal localization,
it is reasonable to speculate the HSCs and MSCs share
some regulatory mechanisms, and accordingly, both
SDF-1 and Wnt5a were reported to affect both HSCs
and MSCs. As a key homing regulator for HSCs [51],
several transplantation studies showed that SDF-1/
CXCR4 axis also play a key role in the localization of
MSCs in the injured tissues [55-57]. On the other hand,
although controversial cellular regulations of Wnt5a on
HSCs via non-canonical pathway were reported probably
due to the dose-dependent nature of Wnt ligands
[52,58], it has been shown that Wnt5a promotes the
osteogenic differentiation of MSCs via non-canonical
pathway and antagonizes the clonogenicity supported by
Wnt3a via canonical pathway [59,60]. Interestingly, HS-
GAGs bind to both SDF-1 and Wnt ligands and regulate
their biological activities by shaping the distribution
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[45,46,61-64]. Accordingly, a previous study suggested
that the reduction in the capacity of hematopoiesis in
patients received chemotherapy was due to the alteration
of GAG profiles in the bone marrow, especially HS-GAGs
[18]. Furthermore, ubiquitous overexpression of HPSE in
transgenic mouse resulted in the increase of HSCs counts
in the bone marrow [65] indicating that HS-GAGs con-
tribute to the composition of stem cell niche microenvir-
onment for HSCs. Although the detail mechanisms
remain elusive, the HPSE secreted by marrow MSCs may
modulate both MSCs and HSCs via the editing of the vici-
nal HS-GAGs profile.
Together with previous findings and our work, three
models are postulated to depict the possible roles of
heparan sulfate in mouse BM-MSCs (Figure 7). Firstly,
HPSE might quench putative external signals that were
mediated by cell surface HSPGs and could inhibit the
homing, migration and self-renewal of MSCs (Figure 7A).
As our data and experimental results from others, SDF-
1/CXCR4 signaling axis plays a key role in MSCs hom-
ing and migration while its ligand receptor interaction is
mediated by cell surface HSPGs [18,38-42]. A possible
quench factor for self-renewal is FGF2 since it decreases
clonogenicity of MSCs and the ligand-receptor inter-
action is mediated by HS-GAGs [66,67]. Secondly,
heparanase might promote the release of self-renewal
factors from extracellular matrix HSPGs and in turn
maintain the stemness of MSCs (Figure 7B). A possible
candidate is Wnt signaling since it has been reported to
be involved in the stemness of MSCs [53,68] and its dis-
tribution is regulated by extracellular HS-GAGs [69].Figure 7 A schematic diagram demonstrates three possible action mo
putative external signals that are mediated by cell surface HSPGs and invol
promote the release of putative self-renewal factors that are originally trapp
and sorted into cell nucleus to modulate the chromatin signatures and alteAccordingly, β-catenin, which is the major player in the
canonical pathway of Wnt signaling, was reported to
transactivate the expressions of Mmp9 and Cxcr4
[34,70]. Thirdly, heparanase might be endocytosed and
sorted into cell nucleus (Figure 7C). Numerous studies
showed that the alterations on the profiles of nuclear
HS-GAGs modulate chromatin-remodeling factors such
as histone acetyltransferases (HATs) [47,71,72]. In ac-
cordance with these results, we observed the alter-
ation in the acetylation levels of histone H4 under
the treatment of heparanase inhibitor. Therefore, this
is also a potential hypothesis that HPSE1 secured the
HATs activities and in turn a set of self-renewal promot-
ing genes were transactivated to maintain the stemness
of MSCs.
Conclusion
In this study, we demonstrated that mouse BM-MSCs
autonomously express HPSE1. Loss of HPSE activity did
not result in the alteration of phenotypes of BM-MSCs
as well as the osteogenic differentiation. It is possible
that the increased expression of Mmp9 compensates
for the loss of HPSE activity. We found that loss of
HPSE activity decreased self-renewal and proliferation
of BM-MSCs. Moreover, HPSE regulated the migration
of BM-MSCs by modulating SDF-1/CXCR4 signaling axis.
Furthermore, HPSE participated in the modification of
histone H4 acetylation in the nucleus of BM-MSCs.
Together, these findings suggest that cell-autonomous
HPSE1 modulates vicinal and nuclear HS-GAGs profiles
of MSCs and in turn participates the regulation of
MSCs biology.dels of HPSE in modulating BM-MSCs. (A) HPSE could modulate
ved in MSCs self-renewal and migration such as SDF-1. (B) HPSE might
ed in the extracellular matrix HSPGs. (C) HPSE could be endocytosed
r the gene expression profiles such as Cxcr4.
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